EDP Sciences logo
Submit your paper
Search
Menu
Home All issues Volume 18 / No 4 (novembre 2012) Med Buccale Chir Buccale, 18 4 (2012) 339-345 References
Open Access
Issue
Med Buccale Chir Buccale
Volume 18, Number 4, novembre 2012
Page(s) 339 - 345
Section Mises au point / Literature reviews
DOI https://doi.org/10.1051/mbcb/2012029
Published online 25 September 2012
  1. Gerecke M. Chemical structure and properties of midazolam compared with other benzodiazepines. Br J Clin Pharmacol 1983;16(Suppl 1):11S–16S. [CrossRef] [PubMed] [Google Scholar]
  2. Reves JG, Fragen RJ, Vinik HR, Greenblatt DJ. Midazolam: pharmacology and uses. Anesthesiology 1985;62:310-24. [CrossRef] [PubMed] [Google Scholar]
  3. Pieri L. Preclinical pharmacology of midazolam. Br J Clin Pharmacol 1983;16(Suppl 1):17S–27S. [CrossRef] [PubMed] [Google Scholar]
  4. Gerecke M, Pieri L. Midazolam. Données chimiques et neuropharmacologie expérimentale. Ann Fr Anesth Reanim 1984;3:155-61. [CrossRef] [Google Scholar]
  5. Garzone PD, Kroboth PD. Pharmacokinetics of the newer benzodiazepines. Clin Pharmacokinet 1989;16:337-64. [CrossRef] [PubMed] [Google Scholar]
  6. Nutt DJ, Malizia AL. New insights into the role of the GABA(A)-benzodiazepine receptor in psychiatric disorder. Br J Psychiatry 2001;179:390-6. [CrossRef] [PubMed] [Google Scholar]
  7. Möhler H, Fritschy JM, Rudolph U. A new benzodiazepine pharmacology. J Pharmacol Exp Ther 2002;300:2-8. [CrossRef] [PubMed] [Google Scholar]
  8. Heizmann P, Eckert M, Ziegler WH. Pharmacokinetics and bioavailability of midazolam in man. Br J Clin Pharmacol 1983;16(Suppl 1):43S–49S. [CrossRef] [PubMed] [Google Scholar]
  9. Allonen H, Ziegler G, Klotz U. Midazolam kinetics. Clin Pharmacol Ther 1981;30:653-61. [CrossRef] [PubMed] [Google Scholar]
  10. Malamed SF. Sedation: a guide to patient management. 5th revised ed. Mosby, St Louis, 2009. [Google Scholar]
  11. Wandel C, Böcker R, Böhrer H, Browne A, Rügheimer E, Martin E. Midazolam is metabolized by at least three different cytochrome P450 enzymes. Br J Anaesth 1994;73:658-61. [CrossRef] [PubMed] [Google Scholar]
  12. Ziegler WH, Schalch E, Leishman B, Eckert M. Comparison of the effects of intravenously administered midazolam, triazolam and their hydroxy metabolites. Br J Clin Pharmacol 1983;16(Suppl 1):63S-69S. [CrossRef] [PubMed] [Google Scholar]
  13. Heizmann P, Ziegler WH. Excretion and metabolism of 14C-midazolam in humans following oral dosing. Arzneimittelforschung 1981;31:2220-3. [PubMed] [Google Scholar]
  14. Dundee JW, Halliday NJ, Harper KW, Brogden RN. Midazolam. A review of its pharmacological properties and therapeutic use. Drugs 1984;28:519-43. [Google Scholar]
  15. Greenblatt DJ, Abernethy DR, Locniskar A, Harmatz JS, Limjuco RA, Shader RI. Effect of age, gender, and obesity on midazolam kinetics. Anesthesiology 1984;61:27-35. [PubMed] [Google Scholar]
  16. Kanto JH. Midazolam: the first water-soluble benzodiazepine. Pharmacology, pharmacokinetics and efficacy in insomnia and anesthesia. Pharmacotherapy 1985;5:138-55. [PubMed] [Google Scholar]
  17. Samuelson PN, Reves JG, Kouchoukos NT, Smith LR, Dole KM. Hemodynamic responses to anesthetic induction with midazolam or diazepam in patients with ischemic heart disease. Anesth Analg 1981;60:802-9. [CrossRef] [PubMed] [Google Scholar]
  18. Pentikäinen PJ, Välisalmi L, Himberg JJ, Crevoisier C. Pharmacokinetics of midazolam following intravenous and oral administration in patients with chronic liver disease and in healthy subjects. J Clin Pharmacol 1989;29:272-7. [CrossRef] [PubMed] [Google Scholar]
  19. Vinik HR, Reves JG, Greenblatt DJ, Abernethy DR, Smith LR. The pharmacokinetics of midazolam in chronic renal failure patients. Anesthesiology 1983;59:390-4. [CrossRef] [PubMed] [Google Scholar]
  20. Bauer TM, Ritz R, Haberthür C, Ha HR, Hunkeler W, Sleight AJ, Scollo-Lavizzari G, Haefeli WE. Prolonged sedation due to accumulation of conjugated metabolites of midazolam. Lancet 1995;346:145-7. [CrossRef] [PubMed] [Google Scholar]
  21. Crevoisier C, Ziegler WH, Eckert M, Heizmann P. Relationship between plasma concentration and effect of midazolam after oral and intravenous administration. Br J Clin Pharmacol 1983;16 (Suppl 1):51S-61S. [CrossRef] [PubMed] [Google Scholar]
  22. Crevoisier C, Eckert M, Heizmann P, Thurneysen DJ, Ziegler WH. Relation between the clinical effect and the pharmacokinetics of midazolam following i.m. and i.v. administration/2nd comm.: Pharmacokinetical aspects. Arzneimittelforschung 1981;31: 2211-5. [PubMed] [Google Scholar]
  23. Persson MP, Nilsson A, Hartvig P. Relation of sedation and amnesia to plasma concentrations of midazolam in surgical patients. Clin Pharmacol Ther 1988;43:324-31. [CrossRef] [PubMed] [Google Scholar]
  24. Rodrigo MR, Clark RN. A study of intravenous sedation with diazepam and midazolam for dentistry in Hong Kong Chinese. Anaesth Intensive Care 1986;14:404-11. [PubMed] [Google Scholar]
  25. Crevoisier C, Ziegler WH, Heizmann P, Dubuis R. Relation entre l’effet clinique et la concentration plasmatique du midazolam chez des sujets volontaires. Ann Fr Anesth Reanim 1984;3:162-7. [CrossRef] [PubMed] [Google Scholar]
  26. Dundee JW, Samuel IO, Toner W, Howard PJ. Midazolam: a water-soluble benzodiazepine. Studies in volunteers. Anaesthesia 1980;35:454-8. [CrossRef] [Google Scholar]
  27. Langlois S, Kreeft JH, Chouinard G, Ross-Chouinard A, East S, Ogilvie RI. Midazolam: kinetics and effects on memory, sensorium, and haemodynamics. Br J Clin Pharmacol 1987;23:273-8. [CrossRef] [PubMed] [Google Scholar]
  28. Platten HP, Schweizer E, Dilger K, Mikus G, Klotz U. Pharmacokinetics and the pharmacodynamic action of midazolam in young and elderly patients undergoing tooth extraction. Clin Pharmacol Ther 1998;63:552-60. [CrossRef] [PubMed] [Google Scholar]
  29. Malamed SF, Nikchevich D Jr, Block J. Anterograde amnesia as a possible postoperative complication of midazolam as an agent for intravenous conscious sedation. Anesth Prog 1988;35:160-2. [PubMed] [Google Scholar]
  30. Rosenbaum NL. The use of midazolam for intravenous sedation in general dental practice. An open assessment. Br Dent J 1985;158:139-40. [CrossRef] [Google Scholar]
  31. Ellis S. Response to intravenous midazolam sedation in general dental practice. Br Dent J 1996;180:417-20. [CrossRef] [PubMed] [Google Scholar]
  32. Dundee JW, Wilson DB. Amnesic action of midazolam. Anaesthesia 1980;35:459-61. [CrossRef] [PubMed] [Google Scholar]
  33. File SE, Easton P, Skelly AM. Amnesia for dental procedures and mood change following treatment with nitrous oxide or midazolam. Int Clin Psychopharmacol 1991;6:169-78. [CrossRef] [PubMed] [Google Scholar]
  34. Hupp JR, Becker LE. Intensity and duration of amnesia from intravenous midazolam given for sedation. J Conn State Dent Assoc 1988;62:80-5. [PubMed] [Google Scholar]
  35. Forster A, Gardaz JP, Suter PM, Gemperle M. I.V. midazolam as an induction agent for anaesthesia: a study in volunteers. Br J Anaesth 1980;52:907-11. [CrossRef] [PubMed] [Google Scholar]
  36. Frölich MA, Arabshahi A, Katholi C, Prasain J, Barnes S. Hemodynamic characteristics of midazolam, propofol, and dexmedetomidine in healthy volunteers. J Clin Anesth 2011;23:218-23. [CrossRef] [PubMed] [Google Scholar]
  37. Rodrigo CR, Rosenquist JB, Cheng CH. Cardiac dysrhythmias with midazolam sedation. Anesth Prog 1990;37:20-3. [PubMed] [Google Scholar]
  38. Aun C, Flynn PJ, Richards J, Major E. A comparison of midazolam and diazepam for intravenous sedation in dentistry. Anaesthesia 1984;39:589-93. [CrossRef] [PubMed] [Google Scholar]
  39. McGimpsey JG, Kawar P, Gamble JA, Browne ES, Dundee JW. Midazolam in dentistry. Br Dent J 1983;155:47-50. [CrossRef] [PubMed] [Google Scholar]
  40. Forster A, Gardaz JP, Suter PM, Gemperle M. Respiratory depression by midazolam and diazepam. Anesthesiology 1980;53:494-7. [CrossRef] [PubMed] [Google Scholar]
  41. Murphy PJ, Erskine R, Langton JA. The effect of intravenously administered diazepam, midazolam and flumazenil on the sensitivity of upper airway reflexes. Anaesthesia 1994;49:105-10. [CrossRef] [PubMed] [Google Scholar]
  42. Alexander CM, Gross JB. Sedative doses of midazolam depress hypoxic ventilatory responses in humans. Anesth Analg 1988;67:377-82. [PubMed] [Google Scholar]
  43. Power SJ, Morgan M, Chakrabarti MK. Carbon dioxide response curves following midazolam and diazepam. Br J Anaesth 1983;55:837-41. [CrossRef] [PubMed] [Google Scholar]
  44. Rodrigo MR, Rosenquist JB. Effect of conscious sedation with midazolam on oxygen saturation. J Oral Maxillofac Surg 1988;46:746-50. [CrossRef] [PubMed] [Google Scholar]
  45. Richards A, Griffiths M, Scully C. Wide variation in patient response to midazolam sedation for outpatient oral surgery. Oral Surg Oral Med Oral Pathol 1993;76:408-11. [CrossRef] [PubMed] [Google Scholar]
  46. Van der Bijl P, Roelofse JA, Joubert JJ, Breytenbach HS. Intravenous midazolam in oral surgery. Int J Oral Maxillofac Surg 1987;16:325-32. [CrossRef] [PubMed] [Google Scholar]
  47. Win NN, Fukayama H, Kohase H, Umino M. The different effects of intravenous propofol and midazolam sedation on hemodynamic and heart rate variability. Anesth Analg 2005;101:97-102. [CrossRef] [PubMed] [Google Scholar]
  48. Zacharias M, Hunter KM, Parkinson R. Respiratory effects of intravenous midazolam. N Z Dent J 1996;92:76-9. [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.